Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2526
Civeo
CVEO
$326M
| $4.52M | ﹤0.01% |
129,217
-27,263
| -17% | -$878K |
2025 Q1
5 quarters
|
|
2527
4D Molecular Therapeutics
FDMT
$688M
| $4.51M | ﹤0.01% |
339,275
+10,896
| +3% | +$106K |
2021 Q1
21 quarters
|
|
2528
Arvinas
ARVN
$479M
| $4.51M | ﹤0.01% |
542,174
+17,000
| +3% | +$159K |
2018 Q4
30 quarters
|
|
2529
OneSpan
OSPN
$663M
| $4.48M | ﹤0.01% |
312,014
-2,448
| -0.8% | -$30.9K |
2013 Q2
52 quarters
|
|
2530
Nextdoor Holdings
NXDR
$1.02B
| $4.47M | ﹤0.01% |
1,970,218
+110,011
| +6% | +$205K |
2021 Q4
18 quarters
|
|
2531
Pacific Biosciences
PACB
$647M
| $4.46M | ﹤0.01% |
2,652,298
+246,802
| +10% | +$359K |
2013 Q2
52 quarters
|
|
2532
Kestra Medical Technologies
KMTS
$1.58B
| $4.45M | ﹤0.01% |
174,972
+2,798
| +2% | +$58.6K |
2025 Q2
4 quarters
|
|
2533
NIQ Global Intelligence PLC
NIQ
$5.42B
| $4.45M | ﹤0.01% |
475,854
+42,410
| +10% | +$410K |
2025 Q3
3 quarters
|
|
2534
MGP Ingredients
MGPI
$308M
| $4.45M | ﹤0.01% |
253,781
-8,365
| -3% | -$152K |
2015 Q2
44 quarters
|
|
2535
ARS Pharmaceuticals
SPRY
$402M
| $4.42M | ﹤0.01% |
551,416
+18,022
| +3% | +$155K |
2022 Q4
14 quarters
|
|
2536
Enanta Pharmaceuticals
ENTA
$348M
| $4.39M | ﹤0.01% |
301,151
+6,180
| +2% | +$83.1K |
2013 Q3
51 quarters
|
|
2537
Advantage Solutions
ADV
$402M
| $4.38M | ﹤0.01% |
101,381
-30,467
| -23% | -$1.08M |
2020 Q4
22 quarters
|
|
2538
Bowhead Specialty Holdings
BOW
$1.12B
| $4.38M | ﹤0.01% |
146,274
+3,765
| +3% | +$97.9K |
2024 Q3
7 quarters
|
|
2539
SITE Centers
SITC
$161M
| $4.35M | ﹤0.01% |
1,094,837
+167,502
| +18% | +$873K |
2013 Q2
52 quarters
|
|
2540
Triple Flag Precious Metals
TFPM
$6.33B
| $4.34M | ﹤0.01% |
144,909
+14,826
| +11% | +$477K |
2025 Q3
3 quarters
|
|
2541
HBT Financial
HBT
$1.29B
| $4.33M | ﹤0.01% |
135,370
+41,309
| +44% | +$1.19M |
2019 Q4
26 quarters
|
|
2542
Hello Group
MOMO
$691M
| $4.29M | ﹤0.01% |
739,822
-307,680
| -29% | -$1.84M |
2025 Q1
5 quarters
|
|
2543
American Public Education
APEI
$898M
| $4.28M | ﹤0.01% |
79,657
-2,199
| -3% | -$121K |
2024 Q2
8 quarters
|
|
2544
Solid Power
SLDP
$491M
| $4.27M | ﹤0.01% |
1,649,314
+116,219
| +8% | +$359K |
2022 Q1
17 quarters
|
|
2545
Grid Dynamics Holdings
GDYN
$651M
| $4.24M | ﹤0.01% |
746,371
+99,352
| +15% | +$615K |
2020 Q2
24 quarters
|
|
2546
Pulse Biosciences
PLSE
$3.58B
| $4.21M | ﹤0.01% |
151,991
+4,223
| +3% | +$99.7K |
2023 Q2
12 quarters
|
|
2547
Farmland Partners
FPI
$465M
| $4.21M | ﹤0.01% |
435,322
+48,561
| +13% | +$517K |
2016 Q2
40 quarters
|
|
2548
Medifast
MED
$129M
| $4.21M | ﹤0.01% |
396,996
-234,543
| -37% | -$2.71M |
2013 Q2
52 quarters
|
|
2549
AEVEX Corp
AVEX
$982M
| $4.15M | ﹤0.01% |
+198,614
| New | +$5.16M |
2026 Q2
0 quarters
|
|
2550
York Water
YORW
$508M
| $4.14M | ﹤0.01% |
135,135
+17,019
| +14% | +$511K |
2013 Q2
52 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.